Alaunos Therapeutics, Inc. (TCRT)
NASDAQ: TCRT · Real-Time Price · USD
2.560
-0.030 (-1.16%)
Apr 29, 2026, 2:05 PM EDT - Market open
Alaunos Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 6 | 7 | 3 | 17 | 155 | 234 | |
| Market Cap Growth | 29.54% | 136.33% | -82.04% | -89.08% | -33.56% | -56.40% | |
| Enterprise Value | 5 | 5 | 1 | 6 | 143 | 172 | |
| Last Close Price | 2.59 | 3.23 | 1.91 | 10.60 | 97.36 | 163.50 | |
| PS Ratio | 1231.94 | 1441.76 | 305.04 | 3396.28 | 53.20 | 587.82 | |
| PB Ratio | 2.83 | 3.35 | 1.48 | 2.69 | 4.03 | 4.03 | |
| P/TBV Ratio | 2.86 | 3.35 | 1.48 | 2.69 | 4.03 | 4.03 | |
| EV/Sales Ratio | 954.94 | 1054.16 | 136.74 | 1241.68 | 49.00 | 431.80 | |
| Debt / Equity Ratio | - | - | - | - | 0.51 | 0.51 | |
| Net Debt / Equity Ratio | -0.64 | -0.64 | -0.53 | -0.96 | -0.51 | -0.80 | |
| Net Debt / EBITDA Ratio | 0.33 | 0.33 | 0.23 | 0.23 | 0.65 | 0.66 | |
| Net Debt / FCF Ratio | 0.47 | 0.47 | 0.22 | 0.20 | 0.66 | 0.72 | |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0 | 0.04 | 0.00 | |
| Quick Ratio | 1.71 | 1.71 | 1.58 | 3.10 | 1.62 | 4.81 | |
| Current Ratio | 2.44 | 2.44 | 3.98 | 4.22 | 2.23 | 4.91 | |
| Return on Equity (ROE) | -198.10% | -198.10% | -111.80% | -156.66% | -78.11% | -86.52% | |
| Return on Assets (ROA) | -92.31% | -92.31% | -54.59% | -48.66% | -25.61% | -37.91% | |
| Return on Capital Employed (ROCE) | -196.20% | -196.20% | -233.30% | -451.80% | -80.30% | -92.80% | |
| Earnings Yield | -69.52% | -57.93% | -153.39% | -206.93% | -24.27% | -33.66% | |
| FCF Yield | -48.17% | -41.16% | -162.96% | -178.66% | -18.95% | -27.69% | |
| Buyback Yield / Dilution | -21.68% | -21.68% | -0.11% | -10.50% | -1.27% | -2.27% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.